FDA Investigator Maressa L Mills
Maressa L Mills has conducted inspections on 119 sites in 2 countries as of 07 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
119
Last Inspection Date:
07 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Costa Rica
FDA Investigators that have inspected at least one site in common with Maressa L Mills:
Alissa C Rice,
Andrew F Saunders,
Andrew J Barrowcliff,
Andrew Saunders,
Anetra E Wyatt,
Anna E Fain,
Barbara S Manson,
Brandon C Heitmeier,
Brian S Lynch,
Caitlin L Almonrode,
Carl A Huffman, III,
Carmen M Chan,
Charles N Dupont,
Charvais S Hill,
Cherie T Parker,
Cheryl G Scott,
Christophe L Boulmay,
Christopher J Adams,
Claire M Minden,
Clendening,
Clifton C Francis,
Clinton J Lott,
Colleen H O'malley,
Combs,
Cynthia L Medlin,
Daniel L Aisen,
Daphne A Videau,
David J Leray,
David R Heiar,
Dawn P Hall,
Debra A Taylor,
Decima L Thompson,
Diana M Guidry,
Donna D Gallien, MPH,
Dyanthony T Jenkins,
Eddie J Rigsby,
Elizabeth D Connell,
Erica M Katherine,
Fonda Dary,
George J Flynn,
Grant D Jones,
Herbert M Corbello,
Herman S Clincy,
Hultman,
Jason D Abel,
Jerry T Hunt,
Jessica A Stephens,
John E Russell, Jr,
Johnathan M Crayton,
Josiah D Davis,
Juanelma H Palmer,
Justin N Henson,
Kari L Batey,
Kenneth R Merritt,
Kerry Ann Latham,
Kimberly L Mcmillan,
Kip J Hanks,
Kriska Earnest,
Krista B Jones,
Krista W Whitten,
Lakisha N Morton,
Larry A Estavan,
Laura L Staples,
LCDR Matthew R Mcnew, MPH, REHS/RS,
Leisha R Shipes,
Lezette M Earhart,
Linda A Gregory Duty,
Lindsay H Bertling,
Lindsey M Schwierjohann,
Llopis,
LTJG Lauren N Shade,
Margaret E Slimbach,
Marissa R Stough,
Mark W Rivero,
Markeesa M Scales,
Marshall H Kinsey,
Mary A Millner,
Meocha V Whaley,
Natalie A Guidry,
Natasha N Mccants,
Nicole D Lyons,
Pamela M Thomas,
Patrick C Dooley,
Peggy A Stogner,
Phuong L Tran,
Priya J Rathnam,
Robert E Hultman,
Samantha J Bradley,
Samuel L Collins,
Sandricka M Mosley,
Sandy L Atkins,
Sarah M Parkinson,
Scott A Watson,
Shannon Atlas,
Shelton L Stribling,
Shondra N Gipson,
Steven D Dittert,
Takiyah S Gilmore Embery,
Thomas B Smith,
Thomas O Morgan,
Tony E Bable,
Travis E Chapman,
Wayne S Fortenberry,
Wendy R Blame,
Whitney M White,
Wilvor K Butler,
Zada L Giles
Maressa L Mills's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2017 | FDA 483 | Wayne Farms LLC - Form 483, 2017-11-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more